Your session is about to expire
← Back to Search
MuST AKT for Kidney Transplant (MuST AKT Trial)
N/A
Waitlist Available
Led By Dr. Shojai
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
English speaking
No obvious contraindication to kidney transplantation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from start date to end date of study recruitment, up to 1 year
Awards & highlights
MuST AKT Trial Summary
This trial is testing a new intervention to help patients with kidney failure identify and communicate with potential living donors. The intervention includes support from a multidisciplinary team to educate the patients' social network. The goal is to increase living kidney donations by 34%.
Who is the study for?
This trial is for English-speaking patients with kidney failure who have completed an 'introduction to kidney transplant' module and are eligible for a transplant. It's not for those who've had previous transplants, have high psychosocial risk scores, already identified a donor, can't read basic health-related English or need multiple organ transplants.Check my eligibility
What is being tested?
The MuST AKT intervention is being tested to see if it helps patients with kidney failure find living kidney donors by providing personalized support from a multidisciplinary team to educate their social networks about donation.See study design
What are the potential side effects?
Since the intervention involves educational and support services rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological stress during the process.
MuST AKT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I speak English.
Select...
I am a suitable candidate for a kidney transplant.
Select...
I have completed the kidney transplant introduction module.
MuST AKT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from start date to end date of study recruitment, up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from start date to end date of study recruitment, up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Living Kidney Donor Evaluation Started
Secondary outcome measures
Contact Living Donor Services
Identified potential advocates
Living Kidney Donor Evaluation Completed
+1 moreOther outcome measures
Advocate and donor attendance at last intervention session
Consent rate
Conversation started
+8 moreMuST AKT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
This arm will receive the MuST AKT intervention, which is a multidisciplinary, tailored person-centered behavioural intervention designed to "help and enable" the potential kidney transplant recipients to achieve what is required to receive a living donor kidney transplantation.
Group II: Usual Care (control)Active Control1 Intervention
In the usual care (control) condition, participants will go through the current standard of care, which is a social worker assessment.
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
886 Previous Clinical Trials
384,740 Total Patients Enrolled
University Hospital FoundationOTHER
7 Previous Clinical Trials
1,348 Total Patients Enrolled
Dr. ShojaiPrincipal InvestigatorUniversity of Alberta
1 Previous Clinical Trials
64 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I speak English.I am eligible for a transplant involving multiple organs.I am a suitable candidate for a kidney transplant.Your SIPAT score is higher than 20, indicating significant psychological and social challenges that may affect your ability to undergo a transplant.You have been identified as a possible kidney donor for someone else.You have had an organ transplant in the past.I have completed the kidney transplant introduction module.You have a score below 19 on a test that measures how well you can read and understand medical information in English.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Usual Care (control)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities to participate in this research initiative?
"According to data provided on clinicaltrials.gov, this specific investigation is not currently accepting participants. It was first advertised in May 12th 2021 and its most recent editing occurred October 6th 2022. Nevertheless, there are 3 other medical trials actively enrolling volunteers at the moment."
Answered by AI
Who is eligible to be involved in this research project?
"This clinical trial is seeking 38 volunteers, aged 18 to 75, with a renal condition. To qualify for this medical study, potential candidates must not possess any clear impediments to successful kidney transplantation."
Answered by AI
Is the enrollment of individuals aged 50 and above an option for this trial?
"This medical trial requires participants to be aged between 18 and 75 in order to meet the enrollment criteria."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Popular Guides
Share this study with friends
Copy Link
Messenger